Rise Advisors’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $348 | Sell |
40
-150
| -79% | -$1.31K | ﹤0.01% | 1462 |
|
2025
Q1 | $1.51K | Buy |
190
+90
| +90% | +$716 | ﹤0.01% | 1195 |
|
2024
Q4 | $909 | Sell |
100
-135
| -57% | -$1.23K | ﹤0.01% | 1086 |
|
2024
Q3 | $2.16K | Hold |
235
| – | – | ﹤0.01% | 1129 |
|
2024
Q2 | $2.3K | Hold |
235
| – | – | ﹤0.01% | 1115 |
|
2024
Q1 | $3.55K | Hold |
235
| – | – | ﹤0.01% | 1107 |
|
2023
Q4 | $5.06K | Hold |
235
| – | – | ﹤0.01% | 379 |
|
2023
Q3 | $4.37K | Sell |
235
-23
| -9% | -$428 | ﹤0.01% | 388 |
|
2023
Q2 | $6.53K | Sell |
258
-20
| -7% | -$506 | 0.01% | 395 |
|
2023
Q1 | $7.2K | Hold |
278
| – | – | 0.01% | 407 |
|
2022
Q4 | $6.58K | Hold |
278
| – | – | 0.01% | 410 |
|
2022
Q3 | $7K | Hold |
278
| – | – | 0.01% | 400 |
|
2022
Q2 | $9K | Buy |
278
+45
| +19% | +$1.46K | 0.01% | 358 |
|
2022
Q1 | $17K | Buy |
233
+110
| +89% | +$8.03K | 0.02% | 267 |
|
2021
Q4 | $11.3K | Buy |
+123
| New | +$11.3K | 0.01% | 316 |
|